Recommendations for Successful Training on Methods of Delivery of Biologics for Cardiac Regeneration. A Report of the International Society for Cardiovascular Translational Research

JACC: Cardiovascular Interventions

Volumn 3, Issue 3, 2010, Pages 265-275

  Dib, Nabil ^a   Menasche, Philippe ^a   Bartunek, Jozef J ^a   Zeiher, Andreas M ^a   Terzic, Andre ^a   Chronos, Nicolas A ^a   Henry, Timothy D ^a   Peters, Nicholas S ^a   Fernández Avilés, Francisco ^a   Yacoub, Magdi ^a   Sanborn, Timothy A ^a   DeMaria, Anthony ^a   Schatz, Richard A ^a   Taylor, Doris A ^a   Fuchs, Shmuel ^a   Itescu, Silviu ^a   Miller, Leslie W ^a   Dinsmore, Jonathan H ^a   Dangas, George D ^a   Popma, Jeffrey J ^a   Hall, Jennifer L ^a   Holmes Jr , David R ^a   more..

^a NONE

Author keywords

catheter; injection; myocardial regeneration; stem cells; training

Indexed keywords

ANGIOGENESIS; CELL TRANSFER; CLINICAL COMPETENCE; CLINICAL EDUCATION; CLINICAL PRACTICE; CORONARY SINUS; ENDOCARDIUM; EPICARDIUM; EXPERIMENTAL ANIMAL; HEART; HEART CATHETERIZATION; HEART INFARCTION; HISTOPATHOLOGY; HUMAN; INTRACORONARY INFUSION; MEDICAL INFORMATION; MUSCLE DEVELOPMENT; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROFESSIONAL DEVELOPMENT; REVIEW; STEM CELL TRANSPLANTATION;

ANIMALS; CERTIFICATION; CLINICAL COMPETENCE; CURRICULUM; EDUCATION, MEDICAL, CONTINUING; EQUIPMENT DESIGN; HEART CATHETERIZATION; HEART DISEASES; HUMANS; MODELS, ANIMAL; MUSCLE DEVELOPMENT; NEOVASCULARIZATION, PHYSIOLOGIC; PROGRAM DEVELOPMENT; REGENERATION; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 77949340085     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2009.12.013     Document Type: Review

References (27)

1. American Heart Association. Heart Disease and Stroke Statistics-2005 Update (2005), American Heart Association, Dallas, TX
2. Hou D., Youssef E.A., Brinton T.J., et al. Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials. Circulation 112 Suppl I (2005) I150-I156
3. Dai W., Hale S.L., Kay G.L., Jyrala A.J., Kloner R.A., and Robert A. Delivering stem cells to the heart in a collagen matrix reduces relocation of cells to other organs as assessed by nanoparticle technology. Regen Med 4 (2009) 387-395
4. Dick A.J., Guttman M.A., Raman V.K., et al. Magnetic resonance fluoroscopy allows targeted delivery of mesenchymal stem cells to infarct borders in swine. Circulation 108 (2003) 2899-2904
5. Amado L.C., Saliaris A.P., Schuleri K.H., et al. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. PNAS 102 (2005) 11474-11479
6. Barbash I.M., Chouraqui P., Baron J., et al. Systemic delivery of bone marrow-derived mesenchymal stem cells to the infracted myocardium: feasibility, cell migration, and body distribution. Circulation 108 (2003) 863-868
7. Sherman W., Martens T.P., Viles-Gonzalez J.F., and Siminiak T. Catheter-based delivery of cells to the heart. Nat Clin Pract Cardiovasc Med 3 Suppl 1 (2006) S58-S60
8. Vale P.R., Losordo D.W., Milliken C.D., et al. Randomized, single-blind, placebo-controlled pilot study of catheter-based myocardial gene transfer for therapeutic angiogenesis using left ventricular electromechanical mapping in patients with chronic myocardial ischemia. Circulation 103 (2001) 2138-2143
9. Biocardia. A Phase I/II, Randomized, Double-Blinded, Placebo-Controlled Study of the Safety and Efficacy of Transendocardial Injection of Autologous Human Cells (Bone Marrow or Mesenchymal) in Patients With Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction. http://clinicaltrials.gov/archive/NCT00102128/2005_12_08 Accessed February 9, 2010
10. de la Fuente L.M., Stertzer S.H., Argentieri J., et al. Transendocardial autologous bone marrow in chronic myocardial infarction using a helical needle catheter: 1 year follow up in an open-label, nonrandomized, single-center pilot study (the TABMMI study). Am Heart J 154 (2007) 79
11. Vale P.R., Losordo D.W., Tkebuchava T., Chen D., Milliken C.E., and Isner J.M. Catheter-based myocardial gene transfer utilizing nonfluoroscopic electromechanical left ventricular mapping. J Am Coll Cardiol 34 (1999) 247-250
12. Dib N., Campbell A., Jacoby D.B., et al. Safety and feasibility of percutaneous autologous skeletal myoblast transplantation in the coil-infarcted swine myocardium. J Pharmacol Toxicol Methods 54 (2006) 73
13. GVVEGF121.10 via an intramyocardial injection catheter in patients with advanced coronary artery disease. J Am Coll Cardiol 41 (2003) 21A
14. Fuchs S., Satler L.F., Kornowski R., et al. Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease: a feasibility study. J Am Coll Cardiol 41 (2003) 1721-1724
15. Dib N., Diethrich E.B., Campbell A., et al. Endoventricular transplantation of allogenic skeletal myoblasts in a porcine model of myocardial infarction. J Endovasc Ther 9 (2002) 313-319
16. de Prado A.P., Cuellas-Ramon C., Regueiro-Purrinos M., et al. Closed-chest experimental porcine model of acute myocardial infarction-reperfusion. J Pharmacol Toxicol Methods 60 (2009) 301-306
17. Dib N. Percutaneous myoblast transplantation: steps in translational research. In: Dib N., Taylor D.A., and Diethrich E.B. (Eds). Stem Cell Therapy and Tissue Engineering for Cardiovascular Repair: From Basic Research to Clinical Applications. 1st edition (2006), Springer, New York, NY 213-230
18. Bolukoglu H., Liedtke A.J., Nellis S.H., Eggleston A.M., Subramanian R., and Renstrom M. An animal model of chronic coronary stenosis resulting in hibernating myocardium. Am J Physiol 263 (1992) H20-H29
19. Bartunek J., Wijns W., Heydnrickx G.R., and Vanderheyden M. Timing of intracoronary bone-marrow-derived stem cell transplantation after ST-elevation myocardial infarction. Nat Clin Pract Cardiovasc Med 3 Suppl 1 (2006) 552-556
20. Vanderheyden M., Vercauteren S., Mansour S., et al. Time-dependent effects on coronary remodeling and epicardial conductance after intracoronary injection of enriched hematopoietic bone marrow stem cells in patients with previous myocardial infarction. Cell Transplant 16 (2007) 919-925
21. Liano R., Epstein S., Zhou R., et al. Intracoronary delivery of mesenchymal stem cells at high flow rates after myocardial infarction improves distal coronary blood flow and decreases mortality in pigs. Catheter Cardiovasc Interv 73 (2008) 251
22. Boekstegers P., Giehrl W., von Degenfeld G., and Steinbeck G. Selective suction and pressure-regulated retroinfusion: an effective and safe approach to retrograde protection against myocardial ischemia in patients undergoing normal and high risk percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 31 (1998) 1525-1533
23. Pohl T., Giehrl W., Reichart B., et al. Retroinfusion-supported stenting in high-risk patients for percutaneous intervention and bypass surgery: results of the prospective randomized myoprotect I study. Catheter Cardiovasc Interv 62 (2004) 323-330
24. Raake P., von Degenfeld G., Hinkel R., et al. Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins: comparison with surgical and percutaneous intramyocardial gene delivery. J Am Coll Cardiol 44 (2004) 1124-1129
25. von Degenfeld G., Raake P., Kupatt C., et al. Selective pressure-regulated retroinfusion of fibroblast growth factor-2 into the coronary vein enhances regional myocardial blood flow and function in pigs with chronic myocardial ischemia. J Am Coll Cardiol 42 (2003) 1120-1128
26. Giordano F.J. Retrograde coronary perfusion: a superior route to deliver therapeutics to the heart?. J Am Coll Cardiol 42 (2003) 1129-1131
27. Menasché P., Alfieri O., Janssens S., et al. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation 117 (2008) 1190-1191